Skip to content
The Policy VaultThe Policy Vault

Odomzo (sonidegib capsules – Novartis) — Cigna

Diffuse Basal Cell Carcinoma Formation (e.g., basal cell nevus syndrome [Gorlin syndrome] or other genetic forms of multiple basal cell carcinoma)

Initial criteria

  • Patient is age ≥ 18 years

Approval duration

1 year